T1	Participants 56 74	patients with COPD
T2	Participants 487 512	patients with stable COPD
T3	Participants 524 670	20 ex-smoking COPD patients with post-bronchodilator forced expiratory volume in one second (FEV(1)) >1.20 L and FEV(1)/forced vital capacity <70%
T4	Participants 1313 1382	patients with chronic obstructive pulmonary disease in a stable phase
T5	Participants 1559 1585	inflammatory lung diseases
